Sign in
4

Changes in Ownership

Marker Therapeutics, Inc. Filed Acc 0001209191-23-014165

Options or other derivatives

  • Chief Medical Officer acquired 51,918 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Koneru Mythili · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-27 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +51,918 51,918 D
Loading xslF345X03/doc4.xml…